Norio Ohmagari, MD, MSc, PhD

Director
National Centre for Global Health and Medicine, Japan

Poster(s):

• (201) Characteristics of Streptococcal Toxic Shock Syndrome Caused by Different Beta-Hemolytic Streptococci Species: A Single-Center Retrospective Study
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (371) Clinical Characteristics and Prognoses for Carbapenem-Resistant Bacterial Infections in Patients with Cancer in Japan: A Multicenter Study from the Multi-Drug Resistant Organisms Clinical Research Network (MDRnet)
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (480) Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (548) Combined Results of the Phase 2a/2b/3 Randomized Controlled Trials of Ensitrelvir for the Treatment of COVID-19 Infection
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (549) Ensitrelvir for the Treatment of COVID-19 Infection: Evaluation of Taste Disorder and Smell Disorder in the Phase 3 Part of the Phase 2/3 SCORPIO-SR Randomized Controlled Trial
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (587) Research and Development of Image Recognition AI to Estimate Bacterial Species using Gram Stain Findings in Aerobic and Anaerobic Blood Culture Bottle
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (719) Stenotrophomonas maltophilia in Japanese hospitals: Clinical characteristics and molecular epidemiology of infection and colonization cases registered in multicenter surveillance network
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (2259) Reversal of antimicrobial consumption: long-term impact of COVID-19 pandemic
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET

• (2778) Retrospective evaluation of effectiveness of Flomoxef for infections due to extended-spectrum β-lactamase-producing Enterobacterales
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET